News

Mar 17

2022

Phanes Therapeutics Announces Three Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

SAN DIEGO, March 16, 2022 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and development in immuno-oncology,...
Read More

Feb 8

2022

Phanes Therapeutics’ antibody patent granted

SAN DIEGO, Feb. 4, 2022 Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and development in immuno-oncology announced...
Read More

Jan 12

2022

Phanes Therapeutics announces the appointment of Vice President of Business Development

SAN DIEGO, Jan. 11, 2022 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that...
Read More

Dec 16

2021

PHANES THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2022 IN SAN FRANCISCO – Company expects to file three INDs in 2022

SAN DIEGO, Dec. 15, 2021 /PRNewswire/ -- Phanes Therapeutics, Inc., an emerging biotech company focused on innovative drug discovery and development in...
Read More

Sep 13

2021

Phanes Therapeutics reveals SPECpair™ technology platform that enhances manufacturability of bispecific antibodies

SAN DIEGO, Sept. 10, 2021 Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative drug discovery research and development in immuno-oncology...
Read More

May 25

2021

Phanes Therapeutics Announces $40 million Series B Financing

SAN DIEGO and SHANGHAI, May 25, 2021 Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative drug discovery in immuno-oncology,...
Read More

Jun 16

2020

Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020

SAN DIEGO, June 16, 2020 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology...
Read More

Dec 12

2019

PHANES THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

​San Diego, California/December 12, 2019 – Phanes Therapeutics, Inc., an emerging biotech company focused on innovative drug discovery in immuno-oncology,...
Read More

Nov 7

2019

PHANES AND FOSUN KITE FORM STRATEGIC ALLIANCE FOR INNOVATIVE CAR-T PRODUCTS TO TREAT SOLID TUMORS

Phanes Therapeutics and Phanes Biopharmaceuticals (“Phanes”) recently formed an important strategic alliance with Fosun Kite Biotechnology (“Fosun Kite”). Under the...
Read More

Sep 17

2019

PHANES AND HANMI ANNOUNCE LICENSING AGREEMENT TO DEVELOP BI- AND/OR MULTI-SPECIFIC ANTIBODIES

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has signed a...
Read More